In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events
- PMID: 33819059
- DOI: 10.7326/ACPJ202104200-043
In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events
Abstract
Guimarães HP, Lopes RD, de Barros E Silva PG, et al. Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve. N Engl J Med. 2020;383:2117-26. 33196155.
Keywords: Anticoagulants; Atrial fibrillation; Bioprosthesis; Mitral valve; Rivaroxaban; Warfarin.
Comment on
-
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve.N Engl J Med. 2020 Nov 26;383(22):2117-2126. doi: 10.1056/NEJMoa2029603. Epub 2020 Nov 14. N Engl J Med. 2020. PMID: 33196155 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous